Steven Cohen’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-16,577
Closed -$27K – 4228
2026
Q2
$27K Buy
+16,577
New +$22.9K ﹤0.01% 3854
2020
Q4
– Sell
-100,000
Closed -$1.03M – 1016
2020
Q3
$1.03M Buy
+100,000
New +$1.02M 0.01% 775

Other funds holding INMB

Steven Cohen's INMB Position: Q3 2026 in Review

Steven Cohen sold out of INmune Bio (INMB) in Q3 2026, closing a stake of 16,577 shares — an estimated $27K sold.

Steven Cohen first reported a position in INMB in Q3 2020 and held it in 2 quarters. The position peaked at $1.03M in Q3 2020. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Steven Cohen reported no remaining INmune Bio position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 16,577 INmune Bio shares in Q3 2026, an estimated $27K.
  • Steven Cohen first reported a position in INmune Bio in Q3 2020 and held it in 2 quarters.
  • Steven Cohen's INmune Bio position peaked at $1.03M in Q3 2020.
  • 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.